Shaffer James P
Insider CIK 1488919 · HALO VP & Chief Commercial Officer · EIGR Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2021-03-12 | 2021-03-15 | 71,250 | — | $0 | 71,250 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award | 2021-03-12 | 2021-03-15 | 11,875 | — | $0 | 29,296 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2020-03-12 | 2020-03-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award | 2020-03-05 | 2020-03-13 | 1,500 | $7.31 | $11.0K | 15,921 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award | 2019-09-05 | 2019-09-06 | 1,500 | $7.95 | $11.9K | 14,421 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2019-03-21 | 2019-03-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award | 2019-03-05 | 2019-03-26 | 1,500 | $7.95 | $11.9K | 12,921 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award | 2018-09-05 | 2019-03-26 | 1,500 | $7.95 | $11.9K | 11,421 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2018-03-14 | 2018-03-16 | 60,000 | — | $0 | 60,000 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award | 2018-03-05 | 2019-03-26 | 1,500 | $8.03 | $12.0K | 9,921 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award | 2017-09-05 | 2019-03-26 | 1,500 | $9.90 | $14.8K | 8,421 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2017-03-09 | 2017-03-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award | 2017-03-06 | 2019-03-26 | 1,301 | $8.20 | $10.7K | 6,921 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | P Buy | 2016-08-18 | 2016-08-19 | 3,125 | $15.70 | $49.1K | 5,620 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | P Buy | 2016-06-13 | 2016-06-14 | 420 | $22.20 | $9.3K | 2,495 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | P Buy | 2016-06-13 | 2016-06-14 | 730 | $22.16 | $16.2K | 1,975 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | P Buy | 2016-06-13 | 2016-06-14 | 100 | $22.17 | $2.2K | 2,075 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | P Buy | 2016-05-23 | 2016-05-23 | 745 | $19.99 | $14.9K | 1,245 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | P Buy | 2016-05-19 | 2016-05-23 | 500 | $19.52 | $9.8K | 500 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2016-03-23 | 2016-09-15 | 60,699 | — | $0 | 60,699 | SEC↗ |
| EIGR Eiger BioPharmaceuticals, | A Award deriv | 2016-03-23 | 2016-03-28 | 60,699 | — | $0 | 60,699 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2014-02-06 | 2014-02-10 | 31,500 | — | $0 | 31,500 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2014-02-06 | 2014-02-10 | 50,000 | $13.10 | $655.0K | 50,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2014-02-04 | 2014-02-04 | 7,500 | — | $0 | 22,500 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2014-02-04 | 2014-02-04 | 4,864 | — | $0 | 54,025 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2014-02-02 | 2014-02-04 | 16,204 | — | $0 | 48,612 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2014-02-02 | 2014-02-04 | 2,084 | — | $0 | 4,166 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2014-02-02 | 2014-02-04 | 1,242 | — | $0 | 49,161 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2014-02-02 | 2014-02-04 | 10,387 | — | $0 | 47,919 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2013-02-04 | 2013-02-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2013-02-04 | 2013-02-06 | 50,000 | $6.55 | $327.5K | 50,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2013-02-02 | 2013-02-05 | 9,993 | — | $0 | 36,293 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2013-02-02 | 2013-02-05 | 1,239 | — | $0 | 37,532 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | P Buy | 2012-11-14 | 2012-11-14 | 20,000 | $5.22 | $104.4K | 26,300 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2012-02-02 | 2012-02-06 | 81,019 | — | $0 | 89,353 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2012-02-02 | 2012-02-06 | 8,334 | — | $0 | 8,334 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award deriv | 2012-02-02 | 2012-02-06 | 16,667 | $11.29 | $188.2K | 16,667 | SEC↗ |